CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
1-Year Return
18.35%
This Quarter Return
-5.59%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.26B
AUM Growth
-$710M
(-8.9%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
69.7%
Holding
93
New
2
Increased
15
Reduced
19
Closed
7
Top Buys
| 1 |
Adobe
ADBE
|
$52.8M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.19M |
| 3 |
TSMC
TSM
|
$5.78M |
| 4 |
HDFC Bank
HDB
|
$5.64M |
| 5 |
Exact Sciences
EXAS
|
$5.52M |
Top Sells
| 1 |
Home Depot
HD
|
$248M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$13.5M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$8.67M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$4.34M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$4.23M |
Sector Composition
| 1 | Healthcare | 18.03% |
| 2 | Financials | 17.71% |
| 3 | Technology | 17.42% |
| 4 | Consumer Discretionary | 13.5% |
| 5 | Communication Services | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humana
HUM
$37.3B
| $25.5M | 0.35% |
52,459
| – | – |
|
27
Intuitive Surgical
ISRG
$167B
| $24.5M | 0.34% |
130,811
+20,000
| +18% | +$3.75M |
|
|
AXNX
28
DELISTED
Axonics, Inc. Common Stock
AXNX
| $22.6M | 0.31% |
320,400
-60,000
| -16% | -$4.23M |
|
29
NovoCure
NVCR
$1.37B
| $22.6M | 0.31% |
296,784
| – | – |
|
|
30
Exact Sciences
EXAS
$10.1B
| $20.1M | 0.28% |
618,894
+170,000
| +38% | +$5.52M |
|
31
Privia Health
PRVA
$2.89B
| $18.7M | 0.26% |
550,000
-120,000
| -18% | -$4.09M |
|
32
BioMarin Pharmaceuticals
BMRN
$11.1B
| $18.1M | 0.25% |
213,851
| – | – |
|
33
Infosys
INFY
$68.1B
| $17.4M | 0.24% |
1,025,514
+183,870
| +22% | +$3.12M |
|
|
OSH
34
DELISTED
Oak Street Health, Inc.
OSH
| $17.3M | 0.24% |
704,933
| – | – |
|
35
Outset Medical
OM
$244M
| $15.9M | 0.22% |
66,667
+16,667
| +33% | +$3.98M |
|
36
Krystal Biotech
KRYS
$4.41B
| $15.7M | 0.22% |
225,809
| – | – |
|
37
Insulet
PODD
$24.5B
| $14.4M | 0.2% |
62,908
| – | – |
|
38
Sarepta Therapeutics
SRPT
$1.95B
| $13.3M | 0.18% |
120,329
| – | – |
|
39
Align Technology
ALGN
$9.95B
| $13.1M | 0.18% |
63,428
| – | – |
|
40
Teleflex
TFX
$5.79B
| $11.7M | 0.16% |
58,000
| – | – |
|
41
Iovance Biotherapeutics
IOVA
$890M
| $11.1M | 0.15% |
1,160,000
| – | – |
|
42
Illumina
ILMN
$15.6B
| $11.1M | 0.15% |
59,601
| – | – |
|
43
Glaukos
GKOS
$5.42B
| $10.5M | 0.14% |
197,212
| – | – |
|
44
iRhythm Technologies
IRTC
$5.86B
| $10M | 0.14% |
80,000
| – | – |
|
45
Service Corp International
SCI
$10.9B
| $9.17M | 0.13% |
158,808
| – | – |
|
46
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $8.92M | 0.12% |
928,464
| – | – |
|
47
Synopsys
SNPS
$111B
| $8.6M | 0.12% |
28,148
| – | – |
|
48
Karyopharm Therapeutics
KPTI
$59.3M
| $8.19M | 0.11% |
100,000
| – | – |
|
49
Insmed
INSM
$30.4B
| $7.39M | 0.1% |
343,110
| – | – |
|
50
Waters Corp
WAT
$18.2B
| $7.21M | 0.1% |
26,748
| – | – |
|